Treating drug dependence with the aid of ibogaine: A qualitative study. Schenberg, E., E., de Castro Comis, M., A., Alexandre, J., F., M., Chaves, B., D., R., Tófoli, L., F., & da Silveira, D., X. Journal of Psychedelic Studies, 1(1):10-19, 4, 2017. ![Treating drug dependence with the aid of ibogaine: A qualitative study [link]](https://bibbase.org/img/filetypes/link.svg "link")
Website abstract bibtex Ibogaine is an alkaloid purported to be an effective drug dependence treatment. However, its efficacy has been hard to evaluate, partly because it is illegal in some countries. In such places, treatments are conducted in underground settings where fatalities have occurred. In Brazil ibogaine is unregulated and a combined approach of psychotherapy and ibogaine is being practiced to treat addiction. To evaluate the safety and efficacy of ibogaine, we conducted a retrospective analysis of data from 75 previous alcohol, cannabis, cocaine and crack users (72% poly-drug users). We observed no serious adverse reactions or fatalities, and found 61% of participants abstinent. Participants treated with ibogaine only once reported abstinence for a median of 5.5 months and those treated multiple times for a median of 8.4 months. This increase was statistically significant (p < 0.001), and both single or multiple treatments led to longer abstinence periods than before the first ibogaine session (p < 0.001). These results suggest that the use of ibogaine supervised by a physician and accompanied by psychotherapy can facilitate prolonged periods of abstinence, without the occurrence of fatalities or complications. These results suggest that ibogaine can be a safe and effective treatment for dependence on stimulant and other non-opiate drugs.
@article{
title = {Treating drug dependence with the aid of ibogaine: A qualitative study},
type = {article},
year = {2017},
identifiers = {[object Object]},
pages = {10-19},
volume = {1},
websites = {http://www.akademiai.com/doi/abs/10.1556/2054.01.2016.002},
month = {4},
id = {205ebd9f-678c-32fd-af41-170736ec2111},
created = {2017-11-10T18:19:02.497Z},
accessed = {2017-10-26},
file_attached = {false},
profile_id = {38c6dbcb-2394-3f18-9217-58d777c08c69},
group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},
last_modified = {2017-12-27T00:58:45.511Z},
read = {false},
starred = {false},
authored = {false},
confirmed = {true},
hidden = {false},
citation_key = {Schenberg2017a},
private_publication = {false},
abstract = {Ibogaine is an alkaloid purported to be an effective drug dependence treatment. However, its efficacy has been hard to evaluate, partly because it is illegal in some countries. In such places, treatments are conducted in underground settings where fatalities have occurred. In Brazil ibogaine is unregulated and a combined approach of psychotherapy and ibogaine is being practiced to treat addiction. To evaluate the safety and efficacy of ibogaine, we conducted a retrospective analysis of data from 75 previous alcohol, cannabis, cocaine and crack users (72% poly-drug users). We observed no serious adverse reactions or fatalities, and found 61% of participants abstinent. Participants treated with ibogaine only once reported abstinence for a median of 5.5 months and those treated multiple times for a median of 8.4 months. This increase was statistically significant (p < 0.001), and both single or multiple treatments led to longer abstinence periods than before the first ibogaine session (p < 0.001). These results suggest that the use of ibogaine supervised by a physician and accompanied by psychotherapy can facilitate prolonged periods of abstinence, without the occurrence of fatalities or complications. These results suggest that ibogaine can be a safe and effective treatment for dependence on stimulant and other non-opiate drugs.},
bibtype = {article},
author = {Schenberg, Eduardo Ekman and de Castro Comis, Maria Angélica and Alexandre, João Felipe Morel and Chaves, Bruno Daniel Rasmussen and Tófoli, Luís Fernando and da Silveira, Dartiu Xavier},
journal = {Journal of Psychedelic Studies},
number = {1}
}
Downloads: 0
{"_id":"4a4EJq9mupSEdu7Ab","bibbaseid":"schenberg-decastrocomis-alexandre-chaves-tfoli-dasilveira-treatingdrugdependencewiththeaidofibogaineaqualitativestudy-2017","downloads":0,"creationDate":"2017-11-14T11:54:38.518Z","title":"Treating drug dependence with the aid of ibogaine: A qualitative study","author_short":["Schenberg, E., E.","de Castro Comis, M., A.","Alexandre, J., F., M.","Chaves, B., D., R.","Tófoli, L., F.","da Silveira, D., X."],"year":2017,"bibtype":"article","biburl":null,"bibdata":{"title":"Treating drug dependence with the aid of ibogaine: A qualitative study","type":"article","year":"2017","identifiers":"[object Object]","pages":"10-19","volume":"1","websites":"http://www.akademiai.com/doi/abs/10.1556/2054.01.2016.002","month":"4","id":"205ebd9f-678c-32fd-af41-170736ec2111","created":"2017-11-10T18:19:02.497Z","accessed":"2017-10-26","file_attached":false,"profile_id":"38c6dbcb-2394-3f18-9217-58d777c08c69","group_id":"d9389c6c-8ab5-3b8b-86ed-33db09ca0198","last_modified":"2017-12-27T00:58:45.511Z","read":false,"starred":false,"authored":false,"confirmed":"true","hidden":false,"citation_key":"Schenberg2017a","private_publication":false,"abstract":"Ibogaine is an alkaloid purported to be an effective drug dependence treatment. However, its efficacy has been hard to evaluate, partly because it is illegal in some countries. In such places, treatments are conducted in underground settings where fatalities have occurred. In Brazil ibogaine is unregulated and a combined approach of psychotherapy and ibogaine is being practiced to treat addiction. To evaluate the safety and efficacy of ibogaine, we conducted a retrospective analysis of data from 75 previous alcohol, cannabis, cocaine and crack users (72% poly-drug users). We observed no serious adverse reactions or fatalities, and found 61% of participants abstinent. Participants treated with ibogaine only once reported abstinence for a median of 5.5 months and those treated multiple times for a median of 8.4 months. This increase was statistically significant (p < 0.001), and both single or multiple treatments led to longer abstinence periods than before the first ibogaine session (p < 0.001). These results suggest that the use of ibogaine supervised by a physician and accompanied by psychotherapy can facilitate prolonged periods of abstinence, without the occurrence of fatalities or complications. These results suggest that ibogaine can be a safe and effective treatment for dependence on stimulant and other non-opiate drugs.","bibtype":"article","author":"Schenberg, Eduardo Ekman and de Castro Comis, Maria Angélica and Alexandre, João Felipe Morel and Chaves, Bruno Daniel Rasmussen and Tófoli, Luís Fernando and da Silveira, Dartiu Xavier","journal":"Journal of Psychedelic Studies","number":"1","bibtex":"@article{\n title = {Treating drug dependence with the aid of ibogaine: A qualitative study},\n type = {article},\n year = {2017},\n identifiers = {[object Object]},\n pages = {10-19},\n volume = {1},\n websites = {http://www.akademiai.com/doi/abs/10.1556/2054.01.2016.002},\n month = {4},\n id = {205ebd9f-678c-32fd-af41-170736ec2111},\n created = {2017-11-10T18:19:02.497Z},\n accessed = {2017-10-26},\n file_attached = {false},\n profile_id = {38c6dbcb-2394-3f18-9217-58d777c08c69},\n group_id = {d9389c6c-8ab5-3b8b-86ed-33db09ca0198},\n last_modified = {2017-12-27T00:58:45.511Z},\n read = {false},\n starred = {false},\n authored = {false},\n confirmed = {true},\n hidden = {false},\n citation_key = {Schenberg2017a},\n private_publication = {false},\n abstract = {Ibogaine is an alkaloid purported to be an effective drug dependence treatment. However, its efficacy has been hard to evaluate, partly because it is illegal in some countries. In such places, treatments are conducted in underground settings where fatalities have occurred. In Brazil ibogaine is unregulated and a combined approach of psychotherapy and ibogaine is being practiced to treat addiction. To evaluate the safety and efficacy of ibogaine, we conducted a retrospective analysis of data from 75 previous alcohol, cannabis, cocaine and crack users (72% poly-drug users). We observed no serious adverse reactions or fatalities, and found 61% of participants abstinent. Participants treated with ibogaine only once reported abstinence for a median of 5.5 months and those treated multiple times for a median of 8.4 months. This increase was statistically significant (p < 0.001), and both single or multiple treatments led to longer abstinence periods than before the first ibogaine session (p < 0.001). These results suggest that the use of ibogaine supervised by a physician and accompanied by psychotherapy can facilitate prolonged periods of abstinence, without the occurrence of fatalities or complications. These results suggest that ibogaine can be a safe and effective treatment for dependence on stimulant and other non-opiate drugs.},\n bibtype = {article},\n author = {Schenberg, Eduardo Ekman and de Castro Comis, Maria Angélica and Alexandre, João Felipe Morel and Chaves, Bruno Daniel Rasmussen and Tófoli, Luís Fernando and da Silveira, Dartiu Xavier},\n journal = {Journal of Psychedelic Studies},\n number = {1}\n}","author_short":["Schenberg, E., E.","de Castro Comis, M., A.","Alexandre, J., F., M.","Chaves, B., D., R.","Tófoli, L., F.","da Silveira, D., X."],"urls":{"Website":"http://www.akademiai.com/doi/abs/10.1556/2054.01.2016.002"},"bibbaseid":"schenberg-decastrocomis-alexandre-chaves-tfoli-dasilveira-treatingdrugdependencewiththeaidofibogaineaqualitativestudy-2017","role":"author","downloads":0},"search_terms":["treating","drug","dependence","aid","ibogaine","qualitative","study","schenberg","de castro comis","alexandre","chaves","tófoli","da silveira"],"keywords":[],"authorIDs":[]}